Acute Coronary Syndrome



Similar documents
URN: Family name: Given name(s): Address:

KIH Cardiac Rehabilitation Program

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Appendix L: HQO Year 1 Implementation Priorities

EMR Tutorial Acute Coronary Syndrome

Educational Goals & Objectives

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

Aligning Incentives for Quality: Pharmacy's Role in Achieving Hospital and National Goals. Objectives. National Organizations: Key Linkages

Management of Acute Coronary Syndrome / NSTEMI

All patients presenting to the Emergency Department with symptoms suggestive of

Mission: Lifeline Recommendations for Criteria for STEMI Systems of Care

105 CMR : STANDARDS GOVERNING CARDIAC REHABILITATION TREATMENT

Cilostazol versus Clopidogrel after Coronary Stenting

Ischemic Heart Disease: Angina Pectoris

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

Cardiac Rehabilitation at AUBMC

Improving PCI Benchmark times in a Non-PCI World

CARDIOLOGY ROTATION GOALS AND OBJECTIVES

Appendix i. All-Wales Cardiac Rehabilitation Pathway. All-Wales Cardiac Rehabilitation Group 2009

Mar. 31, 2011 (202) Improving Quality of Care for Medicare Patients: Accountable Care Organizations

2013 ACO Quality Measures

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Heart Failure Clinical Pathway

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005

PHYSICIAN ORDERS TRANSIENT ISCHEMIC ATTACK (TIA) OBSERVATION

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)

The new Heart Failure pathway

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

International Hospital Inpatient Quality Measures

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Heart Failure Outpatient Clinical Pathway

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION

Heart Center Packages

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Relevant Quality Measures for Critical Access Hospitals

CMS Office of Public Affairs MEDICARE PROPOSES NEW HOSPITAL VALUE-BASED PURCHASING PROGRAM

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, Participating Faculty

Healthcare Data: Secondary Use through Interoperability

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS)

ISSUED BY: TITLE: ISSUED BY: TITLE: President

Community health care services Alternatives to acute admission & Facilitated discharge options. Directory

GENERAL HEART DISEASE KNOW THE FACTS

LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER - SHREVEPORT MEDICAL RECORDS CONTENT/DOCUMENTATION

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

Stroke/VTE Quality Measure Build for Meaningful Use Stage 1

CARDIAC REHABILITATION

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Redefining the NSTEACS pathway in London

Heart Attack: What You Need to Know

ACCOUNTABLE CARE ORGANIZATION QUICK-REFERENCE SETUP GUIDE

Clinical Audit in Hospital Authority. Dr Betty Young Convenor for Clinical Audit, Hospital Authority

Rehabilitation Nurses: Champions for Optimizing Stroke Rehabilitation Across the Continuum of Care

Heart Failure Phased Pathway

HOW TO CITE THIS ARTICLE:

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

convey the clinical quality measure's title, number, owner/developer and contact

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

CARDIAC REHABILITATION Winnipeg Region Annual Report

James F. Kravec, M.D., F.A.C.P

Successful Heart Failure Management Nurse/NP Run Clinics

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)

Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know

Clinical Care Program

Consultation Draft: Clinical Care Standard for Acute Coronary Syndrome December 2013

Jeopardy Topics: THE CLOT STOPS HERE (anticoagulants) SUGAR, SUGAR, HOW D YOU GET SO HIGH (insulins)

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

How to Maximize Your Lab s Value to Cardiac Care Sammie Sue Hendrix Laboratory Director Citizens Medical Center, Victoria Texas

Outpatient/Ambulatory Rehab. Dedicated Trans-disciplinary Team (defined within Annotated References)

Antiplatelet and Antithrombotics From clinical trials to guidelines

The Flex Program MEDICARE BENEFICIARY QUALITY IMPROVEMENT PROJECT

Clinical Pathway Total Hip and Knee Replacement

Rural Health Information Technology Cooperative. Clinician Survey on Quality Improvement, Best Practice Guidelines, and Information Technology

I. Current Cardiac Rehabilitation Requirements

TASK FORCE SUPPLEMENT FOR FUNCTIONAL CAPACITY EVALUATION

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Office of Rural Health Policy MEDICARE BENEFICIARY QUALITY IMPROVEMENT PROJECT

ACO Name and Location Allina Health Minneapolis, Minnesota

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

RE: CMS-3819-P; Medicare and Medicaid Programs; Conditions of Participation for Home Health Agencies

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Utilization Review Cardiac Rehabilitation Services: Underutilized

O: Gerontology Nursing

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

Disclosure. Meaningful use Objectives. Meaningful use. Fundamentals of Transitions of Care (TOC)

The Outpatient Knee Replacement Program at Orlando Orthopaedic Center. Jeffrey P. Rosen, MD

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Case Study High-Performing Health Care Organization April 2011

S Hutton, A Inglis, C McKiernan, S Hearns, P Campbell, M Lindsay

Post discharge tariffs in the English NHS

AHA/ASA Ischemic Stroke Performance Measures

COPD - Education for Patients and Carers Integrated Care Pathway

Service Specification Template Department of Health, updated June 2015

Guidelines for Use of Clopidogrel (Plavix )

CLINICAL PATHWAY FOR BREAST SURGERY: CONSERVING TREATMENT & MAJOR PROCEDURES

ECG may be indicated for patients with cardiovascular risk factors

MAPLES /PHOENIX REHABILITATION REFERRAL REFERRAL DETAILS:

Transcription:

Acute Coronary Syndrome Quality Measures Length of Stay RCC Costs per Case Critical Event(s) Evaluation /Acute Phase ECG ASA on arrival (unless documented contraindication) Troponin STAT, repeat once in 6 hrs. Anticoagulant Therapy Cardiac Cath if indicated Cardiology consult Medication reconciliation addressed Documentation of screening for pneumococcal/influenza (seasonal) vaccine Baseline pain assessment VTE/(DVT) risk assessment Appropriate VTE/(DVT) prophylaxis if applicable Initiate stress testing or cardiac catherization if indicated Progressive Phase Change from IV to PO vasodilator Smoking Cessation Advice/Counseling if indicated Administration of Pneumococcal/Influenza (seasonal) vaccine if eligible Discharge Phase Medication reconciliation addressed Assess understanding of discharge instructions

Complete Day 1 Comprehensive history and physical P Baseline skin assessment and documentation of present on admission P,N Baseline pain assessment** N VTE(DVT) risk assessment ** P,N ACS algorithm/ TIMI risk score (as guides to initial site of treatment) P Cardiology consult** P Education Complete Day 1 Assess barriers to learning P,N Orientation to environment, safety protocols N Infection control procedures/ protocols P,N Medication teaching as appropriate N Evaluation/Acute Phase (1-2 days) Tests Complete Day 1 ECG** (baseline and when symptomatic) Troponin STAT, repeat once in 6 hrs. ** Comprehensive Metabolic Profile, Chest X-ray, CPK PT/PTT/ INR if indicated if on anticoagulants CBC with diff and platelets Guiac stools x 1 as indicated Treatments Cardiac monitoring IV /Tubes/Drains IV access Medications Complete Day 1 Medication Reconciliation addressed** P,N Appropriate VTE(DVT) prophylaxis if applicable** Nasal O2 as ordered Anticoagulant Therapy** ASA on arrival (unless documented contraindication)** Consider ACE I / ARB for LVSD less than 40% (If LVSD known) Nitrate therapy (oral/topical) Clopidogrel daily unless contraindicated GPIIb/IIIa Inhibitors at discretion of interventional cardiologist Activity Ambulate unless specifically ordered to the contrary -p Pyschosocial Patient Outcomes Cardiac discomfort relieved/controlled Admission assessment including smoking history N Initiate plan of care P,N Fall / Risk assessment P,N MRSA/VRE screen if indicated N Documentation of screening for pneumococcal / influenza (seasonal) vaccine** N Explain all tests, procedures, plan of care and expected length of stay P,N Patient and family education as it relates to medications, diet, smoking cessation, diagnosis, activity and signs & symptoms requiring intervention P,N,D,T-p,Ph Fasting lipid profile Initiate stress testing or cardiac catherization if indicated ** Consider stress testing as an outpatient if patient is low risk ASA unless documented contraindication Lipid lowering therapy Evaluate need for GI prophylaxis Appropriate VTE(DVT) prophylaxis if applicable** Diet As Ordered P,N,D Consider Low cholesterol, low fat, low sodium diet P I & O if indicated N Monitor and document bowel and bladder elimination N Assess support network N,CM,SW Initiate discharge plan including appropriate referrals N,CM,SW Safety maintained Assessments completed Acceptable patient comfort level Patient &/or family aware of plan of care ** critical event P = LIP D = Dietician (nutrition) T-r = Respiratory Therapist N = Registered nurse CM = Case Manager T-p = Physical Therapist Ph = Pharmacist SW = Social Worker T-s = Speech/Swallow Therapist

Education Tests Treatments IV /Tubes/Drains Medications Activity Psychosocial Progressive Phase (1-2 days) Reassessment of response to treatment and patient care P,N Monitor effects of medication and assess for adverse drug reactions P,N Pain management P,N Patient and family education as it relates to discharge plan, diagnosis, activity, medications, diet, smoking cessation, signs & symptoms requiring intervention. P,N,T-p,D,SW,T-r Reinforce anticipated length of stay and discharge plan P N,T-r, SW Smoking cessation advice/counseling if indicated** ECG PT,PTT,INR if on anticoagulants CBC with diff and platelets if on glycoprotein inhibitors Consider ECHO if LVSD unknown or not documented Cardiac monitoring IV access Consider conversion of IV meds to PO meds Administration of pneumococcal/influenza(seasonal) vaccine if eligible** N Evaluate for stool softener/laxative ASA (unless documented contraindication) Anticoagulant Therapy Nitrate therapy (oral/topical) Change from IV to PO vasodilator** GPIIb/IIIa Inhibitors Reassess need for nasal O 2 Diet as ordered - Advance as tolerated P,N,D I & O if indicated N Monitor and document bowel and bladder elimination N Ambulate unless specifically ordered to the contrary N,T-p Promote independence with ADL's N N, CM,SW Reassess discharge planning needs Discharge notification P,N,CM,SW Consider discharge if appropriate P Patient Outcomes Safety maintained Ambulating/Performing ADL's w/optimal independence Acceptable patient comfort level ** critical event P = LIP D = Dietician (nutrition) T-s = Speech/Swallow Therapist N = Registered nurse CM = Case Manager Ph = Pharmacist SW = Social Worker T-r = Respiratory Therapist T-p = Physical Therapist

Education Tests Treatments Discharge Phase Reassessment of response to treatment and patient care P,N Monitor effects of medication and assess for adverse drug reactions P,N Pain management P,N Assess patient and family understanding of discharge instructions including diagnosis, activity, medications, pain management, diet, smoking cessation, signs & symptoms requiring intervention, and follow up medical appointment** P,N,D,Ph,T-p,SW (use teach back method) Patient identifies personal risk factors and P,N assists with modification Patient understands importance of activity progression P,N ECG if needed PT/PTT/INR if on anticoagulants D/C cardiac monitor IV /Tubes/Drains D/C IV access Medications Medication reconciliation addressed** P,N ASA (unless documented contraindication) D/C Anticoagulant Therapy if indicated Nitrate therapy (Oral/topical) if clinically indicated D/C Nasal O 2 if ordered Activity Diet as ordered P,N,D Ambulate N,T-p N,CM, SW Psychosocial Discharge plan confirmed Provide referral, support information P,N,CM,SW Patient Outcomes Hemodynamic stability Stable and safe appropriate discharge Patient/family demonstrates understanding of discharge instructions Cardiac discomfort relieved/controlled ** critical event P = LIP D = Dietician (nutrition) T-s = Speech/Swallow Therapist N = Registered nurse CM = Case Manager Ph = Pharmacist SW = Social Worker T-r = Respiratory Therapist T-p = Physical Therapist

References ACS Guideline 1. Uptodate. (2009, September 30). Overview of the management of unstable angina and acute non-st elevation myocardial infarction. Retrieved February 3, 2010, from http://www.uptodate.com 2. Uptodate. (2008, April 21). Cholesterol lowering after an acute coronary syndrome. Retrieved February 18, 2010, from http://www.uptodate.com 3. National Guideline Clearinghouse. (2007). Acute coronary syndromes. A national clinical guideline. Retrieved February 1, 2010, from http://www.guideline.gov 4. Milliman Care Guidelines Inpatient and Surgical Care 14th edition. (2010, February 9). Angina and Acute Coronary Syndromes. Retrieved February 23, 2010, from http://careweb.careguidelines.com/ed14isc/0428100b.htm 5. Hills, D. L., & Lange, R. A. (2009). Optimal Management of Acute Coronary Syndromes. The New England Journal of Medicine, 360(21), 2237-2240. 6. Murphy, S. A., Cannon, C. P., Wiviott, S. D., De Lemos, J. A., Blazing, M. A., McCabe, C. H., et al. (2007). Effect of Intensive Lipid-Lowering Therapy on Mortality after Acute Coronary Syndrome ( a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or atorvastatin Evaluation and Infection Therapy- Thrombolysis in Myocardial Infarction 22 Trials). The American Journal of Cardiology, 100, 1047-1051. This Clinical Guideline has been developed with support from your institution as a member of Long Island Health Network. It is strongly recommended for the treatment of patients with this diagnosis. It does not take into account unusual patient needs which may dictate different plans of care.